feed,title,long_url,short_url
Benzinga,GSK's Jemperli/Chemo Combo Shows Response Rate Of 46% In Head-To-Head Lung Cancer Trial,https://benzinga.com/general/biotech/22/12/29995263/gsks-jemperlichemo-combo-shows-response-rate-of-46-in-head-to-head-lung-cancer-trial,https://da.gd/aSGu3T
